The COALESCE study is a collaborative effort multi-site study based at the Vanderbilt Center for Excellence in Sickle Cell Disease with partners at Children's National Hospital, Johns Hopkins University, and the National Institutes of Health. Our is to gain a better understanding of long-term health outcomes after curative therapies in both children and adults with sickle cell disease.

If you are not a current participant in this study, but are interested in learning more sickle cell curative therapies and sickle cell health effects, please click the "General Information for the Public" button to the right.

For information about our yearly conference on health outcomes after sickle cell curative therapies, please click the "Global Cure SCD Conference Information" button to the right.

If you were provided with information to log in to this website by a member of the COALESCE study team, please enter this information in the login box. Login credentials are unique to each person, so if you do not have login information, please contact us and we will provide this information to you again.

Phone: 314-603-7388 | Email: coalesce@vumc.org